Zomedica Corp (ZOM)
0.1312
0.00 (0.00%)
USD |
NYAM |
Nov 21, 16:00
0.1301
0.00 (0.00%)
After-Hours: 06:43
Zomedica Gross Profit Margin (Quarterly): 72.32% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 72.32% |
| June 30, 2024 | 71.15% |
| March 31, 2024 | 65.75% |
| December 31, 2023 | 69.14% |
| September 30, 2023 | 68.73% |
| June 30, 2023 | 67.24% |
| March 31, 2023 | 69.96% |
| December 31, 2022 | 68.39% |
| Date | Value |
|---|---|
| September 30, 2022 | 73.51% |
| June 30, 2022 | 70.80% |
| March 31, 2022 | 73.05% |
| December 31, 2021 | 75.01% |
| September 30, 2021 | 21.74% |
| June 30, 2021 | -125.0% |
| March 31, 2021 | 57.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-125.0%
Minimum
Jun 2021
75.01%
Maximum
Dec 2021
53.26%
Average
69.14%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| Standard BioTools Inc | 51.73% |
| Ainos Inc | -- |
| LENSAR Inc | 46.28% |
| Intelligent Bio Solutions Inc | 39.76% |
| Adagio Medical Holdings Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.17% |
| Return on Assets | -25.79% |
| Return on Invested Capital | -27.17% |
| Profit Margin (Quarterly) | -95.71% |
| Operating Margin (Quarterly) | -106.3% |
| Return on Net Operating Assets | -42.61% |